Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 134

1.

AP2alpha alters the transcriptional activity and stability of p53.

Stabach PR, Thiyagarajan MM, Woodfield GW, Weigel RJ.

Oncogene. 2006 Apr 6;25(15):2148-59.

PMID:
16288208
2.

Tumor suppressor activity of AP2alpha mediated through a direct interaction with p53.

McPherson LA, Loktev AV, Weigel RJ.

J Biol Chem. 2002 Nov 22;277(47):45028-33. Epub 2002 Sep 10.

3.
4.

ING1 represses transcription by direct DNA binding and through effects on p53.

Kataoka H, Bonnefin P, Vieyra D, Feng X, Hara Y, Miura Y, Joh T, Nakabayashi H, Vaziri H, Harris CC, Riabowol K.

Cancer Res. 2003 Sep 15;63(18):5785-92.

5.

Alternative pathway of transcriptional induction of p21WAF1/Cip1 by cyclosporine A in p53-deficient human glioblastoma cells.

Zupanska A, Adach A, Dziembowska M, Kaminska B.

Cell Signal. 2007 Jun;19(6):1268-78. Epub 2007 Jan 20.

PMID:
17321721
7.

Modulation of the cyclin-dependent kinase inhibitor p21(WAF1/Cip1) gene by Zac1 through the antagonistic regulators p53 and histone deacetylase 1 in HeLa Cells.

Liu PY, Chan JY, Lin HC, Wang SL, Liu ST, Ho CL, Chang LC, Huang SM.

Mol Cancer Res. 2008 Jul;6(7):1204-14. doi: 10.1158/1541-7786.MCR-08-0123.

10.

The plant alkaloid cryptolepine induces p21WAF1/CIP1 and cell cycle arrest in a human osteosarcoma cell line.

Matsui TA, Sowa Y, Murata H, Takagi K, Nakanishi R, Aoki S, Yoshikawa M, Kobayashi M, Sakabe T, Kubo T, Sakai T.

Int J Oncol. 2007 Oct;31(4):915-22.

PMID:
17786325
11.
12.

KAI1 promoter activity is dependent on p53, junB and AP2: evidence for a possible mechanism underlying loss of KAI1 expression in cancer cells.

Marreiros A, Dudgeon K, Dao V, Grimm MO, Czolij R, Crossley M, Jackson P.

Oncogene. 2005 Jan 20;24(4):637-49.

PMID:
15580298
13.

NUPR1 interacts with p53, transcriptionally regulates p21 and rescues breast epithelial cells from doxorubicin-induced genotoxic stress.

Clark DW, Mitra A, Fillmore RA, Jiang WG, Samant RS, Fodstad O, Shevde LA.

Curr Cancer Drug Targets. 2008 Aug;8(5):421-30.

PMID:
18690848
14.

Negative regulation of chemokine receptor CXCR4 by tumor suppressor p53 in breast cancer cells: implications of p53 mutation or isoform expression on breast cancer cell invasion.

Mehta SA, Christopherson KW, Bhat-Nakshatri P, Goulet RJ Jr, Broxmeyer HE, Kopelovich L, Nakshatri H.

Oncogene. 2007 May 17;26(23):3329-37. Epub 2006 Nov 27.

PMID:
17130833
15.

c-Abl tyrosine kinase activates p21 transcription via interaction with p53.

Jing Y, Wang M, Tang W, Qi T, Gu C, Hao S, Zeng X.

J Biochem. 2007 May;141(5):621-6. Epub 2007 Mar 4.

PMID:
17339230
16.

p53 upregulates death receptor 4 expression through an intronic p53 binding site.

Liu X, Yue P, Khuri FR, Sun SY.

Cancer Res. 2004 Aug 1;64(15):5078-83.

17.

Antiproliferative autoantigen CDA1 transcriptionally up-regulates p21(Waf1/Cip1) by activating p53 and MEK/ERK1/2 MAPK pathways.

Tu Y, Wu W, Wu T, Cao Z, Wilkins R, Toh BH, Cooper ME, Chai Z.

J Biol Chem. 2007 Apr 20;282(16):11722-31. Epub 2007 Feb 22.

18.

Copper alters the conformation and transcriptional activity of the tumor suppressor protein p53 in human Hep G2 cells.

Tassabehji NM, VanLandingham JW, Levenson CW.

Exp Biol Med (Maywood). 2005 Nov;230(10):699-708.

PMID:
16246896
19.

p21 Waf1/Cip1 expression by curcumin in U-87MG human glioma cells: role of early growth response-1 expression.

Choi BH, Kim CG, Bae YS, Lim Y, Lee YH, Shin SY.

Cancer Res. 2008 Mar 1;68(5):1369-77. doi: 10.1158/0008-5472.CAN-07-5222.

20.

p53-mediated downregulation of H ferritin promoter transcriptional efficiency via NF-Y.

Faniello MC, Di Sanzo M, Quaresima B, Baudi F, Di Caro V, Cuda G, Morrone G, Del Sal G, Spinelli G, Venuta S, Costanzo F.

Int J Biochem Cell Biol. 2008;40(10):2110-9. doi: 10.1016/j.biocel.2008.02.010. Epub 2008 Feb 17.

PMID:
18372207

Supplemental Content

Support Center